TGFB1 and glioblastoma: Following transient overexpression of constitutively-active SMAD3, a key mediator of TGF-β signaling, we noted significant rescue of GBM cytotoxicity from irinotecan and partial rescue of irinotecan + simvastatin cytotoxicity (Fig. 5g).